See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI101.02▲ 1.56%
← ARYN page
XStocksXray
Market X-Ray report · 22 October 2026

Aryzta AG (ARYN)

SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026

Key indicators

Last closeCHF 41.75
52-week range35.90 – 64.70
Return, 1 month / 3 months+10.9% / −21.2%
Return, 1 year / 3 years−23.2% / −33.9%
TrendBelow its 200-day average
RSI (14)63
Volatility (1 year)33.1%
Worst drawdown (1 year)-43.0%
Average daily value traded5.32M CHF
Dividend yield–

Market X-Ray price-based

24/ 100 · High confidence · ahead of 10% of stocks on this exchange
Trend8
Momentum7
Stability (higher is calmer)29
Liquidity70
Income–

Five-year price chart navy: price · brown: 200-day average

28.4943.9459.4074.8690.312021-102023-012024-042025-072026-10

About the company

Aryzta is a frozen bakery company based in Switzerland. It makes and supplies part-baked and fully baked breads, pastries, croissants, muffins, cookies and other baked goods. Its customers are mainly food service operators, such as restaurants, cafes, hotels and catering businesses, along with retailers that stock frozen and fresh bakery items. The company produces goods under its own brands and as private label products for customers, and it serves markets in Europe and other regions.

On this site Aryzta AG appears as a stock on the SIX Swiss Exchange (Switzerland), code ARYN, with prices in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Aryzta AG (ARYN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 41.75 on 22 October 2026.

Its price-based Market X-Ray is 24 out of 100 (a weak price profile), ranking 203 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 23.2% and over the last three months it fell 21.2%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Aryzta AG (ARYN)

The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange

Lens and metricValueScoreReading
Trend8 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-20.5%
From 52-week high-34.8%
Momentum7 · WeakLagging most stocks on this exchange.
3-month return-21.2%
6-month return-30.3%
12-month return, skipping the last month-30.7%
Stability (higher is calmer)29 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)33.1%
Worst drawdown, 1 year (smaller is calmer)-43.0%
Liquidity70 · StrongTrades actively.
Average daily value traded5.32M CHF
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+4.8%
1 month+10.9%
3 months−21.2%
6 months−30.3%
1 year−23.2%
3 years−33.9%
5 years−15.3%

Signals

50-day / 200-day average39.64 / 52.51
Golden / death cross (60 days)Death, 52 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.15

Technical summary

DailyNeutral8 bullish · 1 neutral · 7 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026